Evidence of thalamic gray matter loss in pediatric multiple sclerosis
Šarlota Mesaroš(University of Belgrade), Massimo Filippi(Vita-Salute San Raffaele University), Lucia Moiola(Vita-Salute San Raffaele University), Martina Absinta(Johns Hopkins University), Gıancarlo Comı(Vita-Salute San Raffaele University), Pierangelo Veggiotti(University of Pavia), Maria A. Rocca(Cognitive Neuroimaging Lab), N. Milani(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Angelo Ghezzi
Cited by 153
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k